New blood test can confirm prostate cancer – and what stage it is at
A new blood test developed by scientists and clinicians is able to detect the presence of prostate cancer and confirm how advanced it is.
Read MoreTag: multiple-authors
Study finds global trends in women’s breast cancer show cause for concern
Breast cancer rates among women globally are on the rise, but new research is uncovering trends related to age and where you live that could help target prevention measures to improve the situation.
Read More
Engineered immune cells recognise, attack human and mouse solid-tumour cancer cells
A method known as CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukaemia. […]
Read More
Discovery of key protein behind cancer relapse and progression can lead to new therapies
Cancer cases have been rising over the years and according to the statistics, the number of people living with cancer […]
Read More
New pathway to attack tumour cells identified
A study led by the Institut de Neurociències (INc-UAB) describes a new strategy to tackle cancer, based on inducing a potent stress in tumour causing cell destruction by autophagy.
Read More
Artificial intelligence can categorise cancer risk of lung nodules
A study published in American Journal of Respiratory and Critical Care Medicine indicates that an artificial intelligence strategy can correctly assess and categorise these indeterminate pulmonary nodules (IPNs).
Read More
Changes to gut microbiome may slow cancer growth in smokers
Changes to the gut microbiome interacted with the immune system to slow the growth of cancer in mice exposed to cigarette smoke, according to research that was selected for presentation at Digestive Disease Week® (DDW) 2020.
Read More
Schizophrenia drug combined with radiation shows promise in treating deadly brain tumours
Researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumours.
Read More
Associations between immune-suppressive and stimulating drugs and novel COVID-19 — a systematic review of current evidence
Cancer and transplant patients with COVID-19 have a higher risk of developing severe and even fatal respiratory diseases, especially as they may be treated with immune-suppressive or immune-stimulating drugs. This review focuses on the effects of these drugs on host immunity against COVID-19.
Read More
How to manage cancer care during COVID-19 pandemic
Experts from the Seattle Cancer Care Alliance (SCCA)—a Member Institution of the National Comprehensive Cancer Network (NCCN)—are sharing insights and advice on how to continue providing optimal cancer care during the novel coronavirus (COVID-19) pandemic.
Read More